Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 917 of 1,261
  1. US 8211664

    Methods and materials for making simvastatin and related compounds

    The Regents of the University of California · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted
  2. US 8211464

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted
  3. US 8211876

    Compositions for treatment of inflammatory diseases

    The Regents of the University of Oklahoma · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted
  4. US 8211891

    Difluoromethyl-containing macrocyclic compounds as hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted
  5. US 8211914

    Inhibitors of diacylglycerol acyltransferase

    Madrigal Pharmaceuticals, Inc. · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted
  6. US 8211941

    Antagonists of the transient receptor potential vanilloid 1 and uses thereof

    The Board of Regents of the University of Texas System · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted
  7. US 8211428

    Protease screening methods and proteases identified thereby

    Catalyst Biosciences, Inc. · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted
  8. US 8211445

    PSM peptides as vaccine targets against methicillin-resistant Staphylococcus

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted
  9. US 8212029

    Method for the production of high-purity 4a, 5, 9, 10, 11, 12,-hexahydro-6H-benzofuro [3a, 3, 2-ef] [2] benzazepine, and the derivatives thereof

    SANOCHEMIA PHARMAZEUTIKA AG · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted
  10. EP 2468274

    Transdermales therapeutisches System zur Verabreichung eines Wirkstoffs

    ACINO AG [DE] · Granted Jun 27, 2012 · Expires Jun 22, 2032

    granted
  11. US 8206715

    Antibodies that bind colony stimulating factor 1 receptor (CSF1R)

    Five Prime Therapeutics, Inc. · Granted Jun 26, 2012 · Expires Jun 21, 2032

    granted
  12. US 8206740

    Once daily formulations of tetracyclines

    Supernus Pharmaceuticals, Inc. · Granted Jun 26, 2012 · Expires Jun 21, 2032

    granted
  13. US 8207142

    Inhibitor of DNA methylation

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 26, 2012 · Expires Jun 21, 2032

    granted
  14. US 8207228

    Calixarene-based peptide conformation mimetics, methods of use, and methods of making

    Regents of the University of Minnesota · Granted Jun 26, 2012 · Expires Jun 21, 2032

    granted
  15. US 8207225

    Conjugated linoleic acid compositions

    Aker Biomarine AS · Granted Jun 26, 2012 · Expires Jun 21, 2032

    granted
  16. US 8207170

    Heterocyclic substituted piperazines with CXCR3 antagonist activity

    Pharmacopeia Drug Discovery, Inc. · Granted Jun 26, 2012 · Expires Jun 21, 2032

    granted
  17. US 8207120

    NELL-1 enhanced bone mineralization

    The Regents of the University of California · Granted Jun 26, 2012 · Expires Jun 21, 2032

    granted
  18. US 8207163

    Compositions, synthesis, and methods of using piperazine based antipsychotic agents

    REVIVA PHARMACEUTICALS, INC. · Granted Jun 26, 2012 · Expires Jun 21, 2032

    granted
  19. US 8207116

    Remedies for ischemia

    Ludwig-Maximilians-Universitat Munchen · Granted Jun 26, 2012 · Expires Jun 21, 2032

    granted
  20. US 8207133

    Peptides that down regulate the activity of plasma membrane transporters including sodium-D-glucose cotransporter SGLT1

    Julius-Maximilians-Universitat Wurzburg · Granted Jun 26, 2012 · Expires Jun 21, 2032

    granted
  21. US 8207114

    Targeted therapeutic proteins

    BIOMARIN PHARMACEUTICAL INC. · Granted Jun 26, 2012 · Expires Jun 21, 2032

    granted
  22. US 8206724

    Method and compositions for vaccination comprising nucleic acid and/or polypeptide sequence of chlamydia

    The Board of Regents of the University of Texas System · Granted Jun 26, 2012 · Expires Jun 21, 2032

    granted
  23. US 8206933

    Boris isoforms and methods of detecting and treating disease

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 26, 2012 · Expires Jun 21, 2032

    granted
  24. US 8206700

    Methods and compositions for treating tularemia

    The Regents of the University of California · Granted Jun 26, 2012 · Expires Jun 21, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.